Ricevi le ultime notizie sulle azioni Neuronetics con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di STIM

Ultime notizie per

Neuronetics

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Penny Stocks

Markets

CNTM

STIM

Scopri le 3 azioni a basso prezzo che stanno attirando l&#39;attenzione degli insider questa settimana e perché.

3 azioni a basso prezzo da tenere d&#39;occhio questa settimana

Long Ideas

News

Insider Trades

Pre-Market Outlook

Trading Ideas

BFLY

HYFM

Le recenti operazioni degli insider che puntano su queste quattro penny stock. Scopri quali azioni stanno attirando l&#39;attenzione e perché.

4 penny stock sotto la lente d&#39;ingrandimento degli insider

Neuronetics Inc

STIMCELL ENERGETICS INC by STIMCELL ENERGETICS INC.

Stimcell Energetics Inc

Press Releases

Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes

Health Care

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Management

Neuronetics Appoints New Chief Financial Officer

Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call

Analyst Ratings

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

Earnings

Neuronetics Reports Second Quarter 2025 Financial and Operating Results

General

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

Accuray

Anteris Technologies Global Corp. - Common Stock

Anteris Technologies Glb

CapsoVision

CVRx

Electromed

Fractyl Health

Vyome Holdings

Hyperfine

Inogen

Kewaunee Scientific Corporation - Common Stock

Kewaunee Scientific

KORU Medical Systems, Inc. - Common Stock

KORU Medical Systems

LENSAR

Lucid Diagnostics

Microbot Medical

Monogram Technologies Inc. - Common Stock

Monogram Technologies

Nyxoah

Orchestra BioMed Holdings, Inc. - Ordinary Shares

Orchestra BioMed Hldgs

Outset Medical

Owlet

Pro-Dex

Profound Medical

Sight Sciences

Shoulder Innovations

Streamex

Stereotaxis

Canaccord Genuity

Citizens Capital Markets

JMP Securities

Piper Sandler

Comments

Neuronetics Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO